These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 2196537)

  • 21. Compatibility of clindamycin phosphate with amikacin sulfate at room temperature and with gentamicin sulfate and tobramycin sulfate under frozen conditions.
    Marble DA; Bosso JA; Townsend RJ
    Drug Intell Clin Pharm; 1986 Dec; 20(12):960-3. PubMed ID: 3816545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progressive increase in antibiotic resistance of gram-negative bacterial isolates. Walter Reed Hospital, 1976 to 1980: specific analysis of gentamicin, tobramycin, and amikacin resistance.
    Cross AS; Opal S; Kopecko DJ
    Arch Intern Med; 1983 Nov; 143(11):2075-80. PubMed ID: 6639227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial activity of cefotiam combinations against Enterobacteriaceae moderately susceptible or resistant to this new cephalosporin.
    Husson MO; Izard D; Leclerc H
    Drugs Exp Clin Res; 1986; 12(4):325-7. PubMed ID: 3459642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 6. Aminoglycosides.
    Marchand S; Boisson M; Mehta S; Adier C; Mimoz O; Grégoire N; Couet W
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30082284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The penetration of aminoglycosides into the alveolar lining fluid of rats. The effect of airway inflammation.
    Valcke Y; Pauwels R; Van der Straeten M
    Am Rev Respir Dis; 1990 Nov; 142(5):1099-103. PubMed ID: 2240833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of analytical inaccuracy on dose adjustment for vancomycin, amikacin, and tobramycin using the Abbottbase Pharmacokinetic Systems.
    Zaera S; Hermida J; Tutor JC
    Ther Drug Monit; 2002 Dec; 24(6):696-700. PubMed ID: 12451284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Resistance to aminoglycosides among gram - negative bacteria].
    Akalin E; Baykal M
    Mikrobiyol Bul; 1982 Jan; 16(1):1-4. PubMed ID: 7144617
    [No Abstract]   [Full Text] [Related]  

  • 28. Aminoglycoside pharmacokinetics and -dynamics: a nonlinear approach.
    Czock D; Giehl M
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):537-9. PubMed ID: 8574502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of serum aminoglycoside concentrations produced by two infusion methods.
    Bosch DE; Williams DN
    Clin Pharm; 1990 Oct; 9(10):777-80. PubMed ID: 2242658
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug interference in amino acid analysis of urines: a graphic presentation on selected pediatric antibiotics.
    Hubbard RW; Slocum R
    Am Clin Lab; 1995 Jul; 14(7):10-1. PubMed ID: 10155052
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current status of aminoglycoside resistance in hospital Enterobacteriaceae].
    Ronco E; Migueres ML; Vacheron F; Guenounou M
    Pathol Biol (Paris); 1988 May; 36(5):430-4. PubMed ID: 3043339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invitro comparative evaluation of aminoglycosides at a cancer centre.
    Biswas SK; Kelkar RS
    Indian J Cancer; 2002; 39(4):135-8. PubMed ID: 12928571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical pharmacology of the most frequently used aminoglucosides: gentamycin, tobramycin and amikacin].
    Cuena Boy R; Azanza Perea JR; Echeverría Echepare LM; Honorato Pérez J
    Rev Med Univ Navarra; 1983 Dec; 27(4):21-7. PubMed ID: 6676898
    [No Abstract]   [Full Text] [Related]  

  • 35. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa.
    Knothe H; Krcméry V; Mitsuhashi S
    Zentralbl Bakteriol A; 1980 Mar; 246(3):373-8. PubMed ID: 6775445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of the antibacterial effects of gentamycin, tobramycin, dibekacin and amikacin in urinary germs].
    Rothenberger K; Friesen A; Streifinger W; Hofstetter A
    Fortschr Med; 1981 Oct; 99(40):1669-72. PubMed ID: 7298004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newer antibiotics.
    Kumar A
    Indian J Pediatr; 1981; 48(394):617-26. PubMed ID: 7327659
    [No Abstract]   [Full Text] [Related]  

  • 38. [In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
    Husson MO; Izard D; Leclerc H
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):466-8. PubMed ID: 3911141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination effect of cefmenoxime with four aminoglycosides on Enterobacteriaceae susceptible and moderately susceptible to this new cephalosporin.
    Husson MO; Izard D; Bryskier A; Vincent P; Leclerc H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):383-7. PubMed ID: 6091368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group.
    Dorman T; Swoboda S; Zarfeshenfard F; Trentler B; Lipsett PA
    Surgery; 1998 Jul; 124(1):73-8. PubMed ID: 9663254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.